期刊文献+

甲地孕酮防治肿瘤化疗呕吐和白细胞减少的临床研究 被引量:11

Clinical study of megestrol acetate on preventing vomiting and leucopenia induced by chemotherapy
在线阅读 下载PDF
导出
摘要 目的:评估甲地孕酮治疗肿瘤化疗引起的呕吐和白细胞减少的疗效。方法:100例肿瘤病人随机分成研究组(50例)和对照组(50例),对照组方案:化疗前半小时静脉推注昂丹司琼8mg,地榆升白片,4片/次,每日3次,全程口服;研究组止吐方案:昂丹司琼和地榆升白片用法同对照组,每例患者自化疗第一天早晨口服甲地孕酮160mg,连用10天。3周为1周期。结果:研究组和对照组急性呕吐发生率分别是40.00%和62.00%(P<0.05),迟发性呕吐发生率分别是30.00%和58.0%(P<0.01),白细胞减少的比率分别是50.00%和72.00%,有显著性差异(P<0.05)。Ⅲ度以上发生率分别是12.00%和26.00%(P>0.05)。结论:在肿瘤化疗中,联合应用甲地孕酮防治呕吐疗效较好,尤其对迟发性呕吐效果更加明显,同时可明显缓解白细胞减少。 Objective:To evaluate the efficacy against vomit and leucopenia duo to chemotherapy for patients with megestrol acetate (MA). Methods: Total of 100 patients was randomized into control group (50 cases) and study group (50 cases), control group: ondansetron 8mg intravenous injection half an hour before chemotherapy, Diyush- engbaipian 4 tablets per time tid. Study group : the administration of ondansetron and Diyushengbaipian was the same as control group, and MA 160mg qd × 10 day from the morning of dayl of chemotherapy, three weeks per cycles. Re- suits: The rates of acute vomitting in study group and control group were respectively 35.00% and 60.00% ( P 〈 0.05), the rates of delayed vomitting were respectively 27.50% and 57.50% ( P 〈 0.01 ). The rates of leuco- penia ( I - Ⅳ ) were respectively 50.00% and 72.00% ( P 〈 0.01 ), the rates of leucopenia ( Ⅲ - Ⅳ ) wei, e re- spectively 12.00% and 26.00% (P 〉 0.05 ). Conclusion: Megestrol acetate can prevent vomitting significantly, es- pecially for delayed vomitting, and can relief leucopenia significantly.
出处 《现代肿瘤医学》 CAS 2010年第5期1000-1002,共3页 Journal of Modern Oncology
关键词 甲地孕酮 化疗 呕吐 白细胞减少 megestrol acetate chemotherapy vomit leucopenia
  • 相关文献

参考文献10

  • 1张天泽 徐光炜.肿瘤学[M].天津:天津科学技术出版社,1996.1209.
  • 2Wiser W,Berger A.Practical management of chemotherapy-duced nausea and vomiting[J].Oncology (Williston Park),2005,19:637.
  • 3林千鹤子,韩少良.抗癌药物毒副反应的对策[J].日本医学介绍,2001,22(11):491-493. 被引量:59
  • 4何舒.化疗呕吐研究进展[J].宁夏医学杂志,2003,25(3):186-188. 被引量:22
  • 5Hesketh PJ,Kris MG,Grunberg SM,et al.Proposal for classifying the acute emetogenicity of cancer chemotherapy[J].J Clin Oncol,1997,15:103.
  • 6Roila F,Donati D,Tamberi S,et al.Delayed emesis:Incidence,pattern,prognostic factors and optimal treatment[J].Support Care Cancer,2002,10:88.
  • 7Fiorica JV,Brunetto VL,Hanjani P,et al.Phase II trial of alternating courses of megestrol acetate and tamoxifen in advanced endometrial carcinoma:a Gynecologic Oncology Group study[J].Gynecol Oncol,2004,92(1):10-14.
  • 8Ruiz Garcia V,Juan O,Perez Hoyos S,et al.Megestrol acetate:a systematic review usefulness about the weight gain in neoplastic patients with cachexia[J].Med Clin(Barc),2002,119(5):166-170.
  • 9Tchekmedyian NS,HS Hariri L,Siau J,et al.Megestrol acetate in cancer anorexia and weight loss[J].Cancer,1992,69:1269.
  • 10雷莉莉.甲孕酮对化疗时骨髓保护作用的临床观察[J].江苏药学与临床研究,2001,9(2):25-26. 被引量:3

二级参考文献6

共引文献624

同被引文献100

引证文献11

二级引证文献126

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部